Business

Movano Health Provides Business Update and Reports Second Quarter 2023 Financial Results

Conference call begins at 2:00 p.m. Pacific time today PLEASANTON, Calif., Aug. 14, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven

articleCorvex, Inc.August 14, 20233/company/movano-inc/news/movano-health-provides-business-update-and-reports-second-quarter-2023-financial-results
Movano Health Provides Business Update and Reports Second Quarter 2023 Financial Results

About this update from Corvex, Inc.

[{"type":"text","content":"Conference call begins at 2:00 p.m. Pacific time today\nPLEASANTON, Calif., Aug. 14, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, reported financial results for the three months ending June 30, 2023 and provided a business update.\n\n \n \n \n \n \n \n\n \nKey highlights from the second quarter and recent weeks include:\nMovano Health demonstrated significant progress with the development of the Evie Ring, as well as fulfilling the requirements of its FDA submission. The Company validated a recently released, high-performance sensor that could improve the efficacy of the ring and help position the Company's first commercial product for success. Given expected implementation and testing of the sensor and related solution enhancements, the Company plans to launch Evie before Black Friday 2023.Movano Health successfully submitted its first 510(k) application to the FDA for the Evie Ring's pulse oximeter, making Evie one of the first consumer wearables to seek FDA clearance as a medical device. The submission recently passed an initial review for completeness and is now under full review by the FDA.The Evie Ring continues to generate strong consumer interest and has reached a major milestone through strategic paid and organic social media and email content. Year-to-date, more than 600,000 people have visited eviering.com and over 100,000 individuals signed up to receive updates about Evie's release, demonstrating momentum for the upcoming launch.The Company is preparing for its second round of beta programs ahead of the Evie Ring's commercial launch. Beta partners include a global athletic apparel company, a major health insurer and a leading remote patient monitoring company.Movano Health announced the formation of its Medical Advisory Board. The initial panel is composed of healthcare industry subject matter experts in women's health, mental health, and sleep, who will serve as trusted advisors to the Evie team regarding the development of its medical-grade smart ring for women and provide insights to establish Evie as a highly credible health and wellness resource.With an eye for future analytes, in May, the Company completed an IRB-approved clinical study on over 50 volunteers in the Movano ...

More updates from Corvex, Inc.